Hyperacidity, Reflux & Ulcer Drug Manufacturing

Trusted Hyperacidity, Reflux & Ulcer Drug Manufacturers in India Reliable CDMO & Third Party Pharmaceutical Manufacturing Partner

Delwis - A Reliable Pharmaceutical Manufacturing Company Built for Long-Term Partnerships

Delwis Healthcare operates as a third party pharmaceutical manufacturer and CDMO pharma company, supporting pharmaceutical brands, exporters, and healthcare companies with scalable, compliant, and efficient manufacturing solutions for hyperacidity, reflux, and ulcer formulations. As a professionally managed pharmaceutical manufacturing company, we work closely with our partners across formulation development, commercial manufacturing, packaging, and regulatory support. Our focus is on consistency, quality assurance, and long-term collaboration rather than transactional manufacturing.

With a strong operational base in India, Delwis Healthcare is positioned as a dependable pharma manufacturing company in India, catering to both domestic and international requirements for gastrointestinal and acid-related disorder therapies.

Our Vision

Quality, Manufacturing & Compliance Framework

Manufacturing of hyperacidity, reflux, and ulcer products at Delwis Healthcare follows WHO-GMP compliant processes supported by a structured Quality Management System. Key quality and manufacturing controls include:

  • Approved and qualified raw material sourcing
  • Validated manufacturing and cleaning processes
  • Finished product testing and controlled batch release
  • Ethical, transparent, and responsible business practices
  • This framework ensures consistent quality, safety, and therapeutic effectiveness across all hyperacidity, reflux, and ulcer products.

Delwis Approach: Market Relevance & Commercial Viability

The hyperacidity, reflux, and ulcer segment requires formulation precision, regulatory alignment, and therapeutic reliability. Our approach focuses on controlled manufacturing, commercial viability, and supply reliability.

Portfolio planning aligned with current gastrointestinal therapy demand
Flexible batch sizes from launch to commercial scale
Predictable production schedules and delivery timelines

Packaging, Labeling & Regulatory Alignment

Beyond manufacturing, we support our partners with structured and execution-driven services that enhance market readiness and long-term growth.

Formulation Support

Optimised hyperacidity, reflux, and ulcer formulations aligned with regulatory standards.

Regulatory Coordination

Documentation support for domestic and export market approvals.

Commercial Batch Planning

Scalable manufacturing aligned with demand forecasting.

Packaging & Labeling Compliance

Country-specific packaging aligned with regulatory norms.

Why Choose Delwis for Hyperacidity, Reflux & Ulcer Drug Manufacturing in India

Delwis Healthcare stands out among hyperacidity, reflux, and ulcer drug manufacturers in India because of our execution discipline, quality systems, and long-term partnership approach.

WHO-GMP aligned manufacturing ecosystem
Strong QA/QC and audit-ready systems
Experience as a CDMO pharma company and CMO pharma company for Hyperacidity, Reflux & Ulcer Drugs
Reliable supply continuity for gastrointestinal care products
Commercially viable pricing without compromising quality

Whom We Work With for Hyperacidity, Reflux & Ulcer Products

We collaborate with pharmaceutical companies seeking a reliable hyperacidity, reflux, and ulcer manufacturer with structured third party manufacturing capabilities.

Our manufacturing services support:

Pharmaceutical brands expanding gastrointestinal therapy portfolios

Companies outsourcing acid-related disorder drug manufacturing

Firms requiring scalable third party pharma manufacturer support

Product NameCompositionClass
Delom - 20Omeprazole 20mg Cap.

Capsules, Hyperacidity / Reflux / Ulcer

Details
Panovit OPantoprazole 40mg + Ondansetron 4mg Tablet

Hyperacidity / Reflux / Ulcer, Tablets

Details
Vitaraft SuspSodium alginate 250mg + Sodium bicarbonate 133.5mg + Calcium carbonate 80mg

Hyperacidity / Reflux / Ulcer

Details
Rabacid - DSRRabeprazole 20mg+Domperidone 30mg SR Cap.

Capsules, Hyperacidity / Reflux / Ulcer

Details
Rabacid - 20Rabeprazole 20mg Tab.

Tablets, Hyperacidity / Reflux / Ulcer

Details
Pentadel - DSRPantoprazole 40mg+Domperidone 30mg SR Cap.

Hyperacidity / Reflux / Ulcer

Details
Esodel - DSREsomeprazole 40mg + Domperidone 30 mg SR Cap.

Capsules, Hyperacidity / Reflux / Ulcer

Details
Gasodel SuspMegaldrate 400mg + Simethicone 20mg Susp.

Hyperacidity / Reflux / Ulcer

Details
Delom - DOmeprazole 20mg+Domperidone 10mg Cap.

Capsules, Hyperacidity / Reflux / Ulcer

Details
Laxitin SuspLiquid Parafin IP 1.25ml+ Milk of Magnesa IP 3.75 ml+ Sodium Picosulphate 3.33mg susp

Hyperacidity / Reflux / Ulcer

Pentadel - DPantoprazole 40mg+ Domperidone 10mg Tab

Tablets, Hyperacidity / Reflux / Ulcer

Details
Laxifin SuspLiquid Parafin IP 1.25ml+ Milk of Magnesia IP 3.75 ml+ Sodium Picosulphate 3.33mg Susp

Hyperacidity / Reflux / Ulcer

Details
Delacid GelSucralfate 1gm + Oxetacaine 20mg Susp

Hyperacidity / Reflux / Ulcer

Details
Panol LSRPantoprazole EC 40mg + Levosulpride SR 75mg Cap

Capsules, Hyperacidity / Reflux / Ulcer

Details
Rabacid - LSRRabeprazole 20mg + Levosulpride 75mg SR Cap.

Capsules, Hyperacidity / Reflux / Ulcer

Details
Pentadel - 40Pantoprazole 40mg Tab.

Tablets, Hyperacidity / Reflux / Ulcer

Details
Dicaine GelAlluminium Hydroxide 0.291gm + Magnesium Hydroxide 98mg + Oxetacaine 10mg Susp

Hyperacidity / Reflux / Ulcer

Details
Esodel - 40Esomeprazole 40mg Tab

Tablets, Hyperacidity / Reflux / Ulcer

Details

Start Your Hyperacidity / Reflux / Ulcer Manufacturing Project

If you are looking for a reliable tablet manufacturing company or third party pharma manufacturer for hyperacidity, reflux, and ulcer formulations, Delwis Healthcare is ready to support your requirements.

No form fields available.

FAQ

Hyperacidity, Reflux & Ulcer Manufacturing & Franchise

These FAQs address common questions about Delwis Healthcare’s hyperacidity, reflux, and ulcer manufacturing capabilities, WHO-GMP compliance, franchise and third-party partnership models, regulatory support, and supply reliability for both domestic and export markets.

Yes. Delwis Healthcare operates as a CDMO and third party pharmaceutical manufacturer supporting hyperacidity, reflux, and ulcer formulations under WHO-GMP compliant systems.